Testicular cancer differential diagnosis: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
No edit summary
Anmol Pitliya (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators, Widget editors
9,217 edits
No edit summary
Line 18: Line 18:
|-
|-
| style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |'''Symptoms'''
| style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |'''Symptoms'''
! rowspan="2" |Physical examination
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
|-
|-
!Lab Findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
|-
|-
| rowspan="5" |Germ Cell
| rowspan="5" style="background: #DCDCDC; padding: 5px; text-align: center;" |Germ Cell
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Seminoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Seminoma
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 34: Line 34:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Embryonal carcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Embryonal carcinoma
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 45: Line 45:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Yolk sac tumor
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Yolk sac tumor
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 55: Line 55:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Teratoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Teratoma
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 65: Line 65:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Choriocarcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Choriocarcinoma
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
!
!
!Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;"|Diseases
!Unilateral/Bilateral
! style="background: #4479BA; color: #FFFFFF; text-align: center;"|Unilateral/Bilateral
!History
! style="background: #4479BA; color: #FFFFFF; text-align: center;"|History
!Metastasis
! style="background: #4479BA; color: #FFFFFF; text-align: center;"|Metastasis
!Genetics
! style="background: #4479BA; color: #FFFFFF; text-align: center;"|Genetics
!Symptoms
! style="background: #4479BA; color: #FFFFFF; text-align: center;"|Symptoms
! rowspan="1" colspan="1" |Physical exam  
! style="background: #4479BA; color: #FFFFFF; text-align: center;"|Physical exam  
!Lab Findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;"|Lab Findings
!Imaging  
! style="background: #4479BA; color: #FFFFFF; text-align: center;"|Imaging  
|-
|-
| rowspan="3" |Non germ cell
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Non germ cell
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Leydig cell tumor
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Leydig cell tumor
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 97: Line 97:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sertoli cell tumor
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Sertoli cell tumor
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 107: Line 107:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Testicular lymphoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Testicular lymphoma
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 117: Line 117:
|-
|-
| colspan="2" |Carcinoma in situ of the testicle
| colspan="2" |Carcinoma in situ of the testicle
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|
| style="background: #F5F5F5; padding: 5px;" |
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|}
|}


Revision as of 20:21, 22 January 2019

Testicular cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Testicular cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Testicular cancer differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Testicular cancer differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Testicular cancer differential diagnosis

CDC on Testicular cancer differential diagnosis

Testicular cancer differential diagnosis in the news

Blogs on Testicular cancer differential diagnosis

Directions to Hospitals Treating Testicular cancer

Risk calculators and risk factors for Testicular cancer differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Testicular cancer must be differentiated from epididymitis, hematocele, hydrocele, spermatocele, granulomatous orchitis, and varicocele.

Differentiating Testicular cancer from other Diseases

Testicular cancer must be differentiated from:

Diseases Unilateral/Bilateral History Metastasis Genetics Clinical manifestations Para-clinical findings
Symptoms Physical examination
Lab Findings Imaging
Germ Cell Seminoma
Embryonal carcinoma
Yolk sac tumor
Teratoma
Choriocarcinoma
Diseases Unilateral/Bilateral History Metastasis Genetics Symptoms Physical exam Lab Findings Imaging
Non germ cell Leydig cell tumor
Sertoli cell tumor
Testicular lymphoma
Carcinoma in situ of the testicle

References


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Testicular_cancer_differential_diagnosis&oldid=1539155"